Who is leading the Quit2Heal study?
The Principal Investigator for Quit2Heal is Jonathan Bricker, PhD, a scientist who specializes in smoking cessation and is a Full Professor at the Fred Hutchinson Cancer Center and Affiliate Professor at the University of Washington. He has published over 90 peer-reviewed scientific articles.
The Co-Investigators for Quit2Heal are Jamie Ostroff at Memorial Sloan Kettering who is Vice Chair for Research in the Department of Psychiatry & Behavioral Sciences and Founder/Director of the Tobacco Treatment Program at Memorial Sloan Kettering Cancer Center, and Lee Westmaas who is the Scientific Director of Tobacco Research at the American Cancer Society.
Why are we doing the Quit2Heal study?
To help cancer patients quit smoking so they have better outcomes from treatment.
Our goal is to test 2 quit-smoking smartphone apps and learn which one is most useful to help cancer patients quit. Patients who quit smoking respond better to treatment and heal faster, and decrease their long-term risks.
What is the Fred Hutchinson Cancer Center?
Fred Hutchinson Cancer Center is a world leader in research to prevent, detect, and treat cancer and other life-threatening diseases. Our world-renowned researchers have received three Nobel Prizes and many other major awards. We're located in Seattle, Washington.
How do we keep your information safe?
- Your contact information (name, phone number, email) is kept apart from all of your survey information
- This website is encrypted for privacy and protection
- This site's server (where all of the site's information is kept) is protected by a hardware firewall (another level of security)